KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $11.1 million.

  • Fulgent Genetics' Cash from Operations rose 17161.65% to $11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 8612.3%. This contributed to the annual value of $21.1 million for FY2024, which is 2200.87% down from last year.
  • Fulgent Genetics' Cash from Operations amounted to $11.1 million in Q3 2025, which was up 17161.65% from -$30.2 million recorded in Q2 2025.
  • Fulgent Genetics' 5-year Cash from Operations high stood at $233.2 million for Q1 2021, and its period low was -$30.2 million during Q2 2025.
  • Over the past 5 years, Fulgent Genetics' median Cash from Operations value was $11.1 million (recorded in 2022), while the average stood at $43.0 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first surged by 1697020.5% in 2021, then plummeted by 80410.74% in 2025.
  • Over the past 5 years, Fulgent Genetics' Cash from Operations (Quarter) stood at $77.1 million in 2021, then plummeted by 56.92% to $33.2 million in 2022, then plummeted by 55.03% to $14.9 million in 2023, then soared by 67.53% to $25.0 million in 2024, then tumbled by 55.6% to $11.1 million in 2025.
  • Its Cash from Operations stands at $11.1 million for Q3 2025, versus -$30.2 million for Q2 2025 and -$4.4 million for Q1 2025.